Filing Details

Accession Number:
0001415889-24-007517
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-11 16:43:31
Reporting Period:
2024-03-08
Accepted Time:
2024-03-11 16:43:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1320414 Select Medical Holdings Corp SEM () PA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
918697 A Robert Ortenzio C/O Select Medical Holdings Corporation
4714 Gettysburg Rd
Mechanicsburg PA 17055
Executive Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-08 50,000 $28.30 6,739,668 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,279,000 Indirect By the Robert A. Ortenzio Descendants Trust
Common Stock 3,804,805 Indirect By the Rocco A. Ortenzio Separate Exempt Descendants Trust
Common Stock 280,415 Indirect By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio
Common Stock 280,415 Indirect By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio
Common Stock 280,415 Indirect By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio
Footnotes
  1. These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $28.595, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
  3. The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.